financetom
Business
financetom
/
Business
/
What's Going On With Roku Stock Ahead Of Earnings?
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
What's Going On With Roku Stock Ahead Of Earnings?
Apr 23, 2024 9:31 AM

Roku, Inc. ( ROKU ) shares are trading higher Tuesday ahead of its earnings report on Thursday. 

What To Know: 

Roku ( ROKU ) shares dipped last week in sympathy with Netflix, Inc. ( NFLX ) which fell after it reportedfirst-quarter results and announced it will stop releasing subscription figures each quarter. 

Last Friday, Wedbush analyst Michael Pachter maintained an Outperform rating on Roku ( ROKU ), but lowered the price target from $120 to $80. Benchmark reiterated its Buy rating and $115 price target on the stock.

Roku ( ROKU ) is set to report its first-quarter financial results after the market close on Thursday and will host a conference call to discuss the results at 5:00 p.m. the same day. According to estimates from Benzinga Pro, analysts expect the company to report losses of 61 cents per share and quarterly revenue of $848.616 million. 

Related News: What’s Going On With Luxury EV-Maker Lucid’s Stock?

Will ROKU Stock Go Up?

When trying to assess whether or not Roku ( ROKU ) will trade higher from current levels, it's a good idea to take a look at analyst forecasts.

Wall Street analysts have an average 12-month price target of $90.60 on Roku ( ROKU ). The Street high target is currently at $120 and the Street low target is $45. Of all the analysts covering Roku ( ROKU ), 7 have positive ratings, no one has neutral ratings and 3 have negative ratings.

In the last month, 4 analysts have adjusted price targets. Here's a look at recent price target changes [Analyst Ratings]. Benzinga also tracks Wall Street's most accurate analysts. Check out how analysts covering Roku ( ROKU ) have performed in recent history.

Stocks don't move in a straight line. The average stock market return is approximately 10% per year. Roku ( ROKU ) is 5.72% up year-to-date. The average analyst price target suggests the stock could have further upside ahead.

For a broad overview of everything you need to know about Roku ( ROKU ), visit here. If you want to go above and beyond, there's no better tool to help you do just that than Benzinga Pro. Start your free trial today.

ROKU Price Action: According to Benzinga Pro, Roku ( ROKU ) shares are up 3.53% at $60.58 at the time of publication Tuesday.

Image: Shutterstock

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Google agrees $36 million fine for anti-competitive deals with Australia telcos
Google agrees $36 million fine for anti-competitive deals with Australia telcos
Aug 17, 2025
SYDNEY, Aug 18 (Reuters) - Google agreed on Monday to pay a A$55 million ($35.8 million) fine in Australia after the consumer watchdog found it had hurt competition by paying the country's two largest telcos to pre-install its search application on Android phones, excluding rival search engines. The fine extends a bumpy period for the Alphabet-owned internet giant in Australia,...
AI infrastructure firm TensorWave raises $100 million in latest funding
AI infrastructure firm TensorWave raises $100 million in latest funding
May 26, 2025
(Reuters) -TensorWave, a Las Vegas-based startup, announced on Wednesday that it has secured $100 million in the latest funding round, as it aims to capitalize on the rapidly expanding AI infrastructure market. The company, however, did not disclose the valuation at which the funding was raised. The Series A funding round was led by Magnetar and AMD Ventures along with...
Novo Nordisk strikes $2.2 billion deal with Septerna to develop new obesity treatments
Novo Nordisk strikes $2.2 billion deal with Septerna to develop new obesity treatments
May 26, 2025
COPENHAGEN, May 14 (Reuters) - Novo Nordisk has struck a collaboration and licensing deal with U.S. biotech Septerna ( SEPN ) to develop oral small molecule medicines for obesity, type 2 diabetes and other cardio-metabolic diseases that could be worth up to $2.2 billion for Septerna ( SEPN ), they said on Wednesday. Novo, maker of the wildly popular Wegovy...
Boyd Group Q1 Adjusted Net Earnings Drop 77%
Boyd Group Q1 Adjusted Net Earnings Drop 77%
May 26, 2025
07:01 AM EDT, 05/14/2025 (MT Newswires) -- Boyd Group Services ( BYDGF ) on Wednesday reported a 77% drop in adjusted net earnings, noting a decline in sales and market headwinds. Adjusted net earnings was US$2.2 million, or US$0.10 per share, down from US$9.4 million, or US$0.44 per share and missing the US$0.14 earnings per share consensus estimate compiled by...
Copyright 2023-2026 - www.financetom.com All Rights Reserved